// App-Quantinova.ai

: Factors Associated with Bleeding Events in Patients Receiving Rivaroxaban for Venous Thromboembolism: A Real World Experience

Researchers

Presenter

  • Ankit Mangla

Principal Investigators

  • Muhammad Umair Mushtaq

  • Koosha Paydary

  • Hashim Mann

  • Jiaxiang Liu

  • Jayasree Krishnan

  • Tauseef Akhtar

  • Jishanth Mattumpuram

  • Aakash Putta

  • Alok Uprety

  • Yanting Wang

  • Barbra Yim

  • Thomas Lad

Medical Centers

  • Division of Hematology and Oncology, The John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

  • Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI

  • Department of Medicine, John H. Stroger Jr, Hospital of Cook County, Chicago, IL

  • Internal Medicine, Stroger Hospital of Cook County, Chicago, IL

  • Department of Medicine, John H. Stroger Jr, Hospital of Cook County, Chicago, IL

  • Department of Medicine, John H. Stroger Jr, Hospital of Cook County, Chicago, IL

  • Department of Medicine, John H. Stroger Jr, Hospital of Cook County, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved